DK0738152T3 - Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer - Google Patents

Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer

Info

Publication number
DK0738152T3
DK0738152T3 DK95907293T DK95907293T DK0738152T3 DK 0738152 T3 DK0738152 T3 DK 0738152T3 DK 95907293 T DK95907293 T DK 95907293T DK 95907293 T DK95907293 T DK 95907293T DK 0738152 T3 DK0738152 T3 DK 0738152T3
Authority
DK
Denmark
Prior art keywords
colon cancer
hydroxy
chemopreventive
phenylazobenzoic acid
acid derivatives
Prior art date
Application number
DK95907293T
Other languages
English (en)
Inventor
Lorin K Johnson
Marvin H Sleisenger
Original Assignee
Salix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salix Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0738152T3 publication Critical patent/DK0738152T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK95907293T 1994-01-07 1995-01-06 Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer DK0738152T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/178,578 US5498608A (en) 1994-01-07 1994-01-07 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents

Publications (1)

Publication Number Publication Date
DK0738152T3 true DK0738152T3 (da) 2006-01-30

Family

ID=22653104

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95907293T DK0738152T3 (da) 1994-01-07 1995-01-06 Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer

Country Status (18)

Country Link
US (1) US5498608A (da)
EP (1) EP0738152B1 (da)
JP (4) JPH09510958A (da)
CN (1) CN1140994A (da)
AT (1) ATE308327T1 (da)
AU (1) AU691869B2 (da)
CA (1) CA2180571C (da)
CZ (1) CZ286460B6 (da)
DE (1) DE69534564T2 (da)
DK (1) DK0738152T3 (da)
ES (1) ES2248796T3 (da)
FI (1) FI962735A (da)
HU (1) HUT74512A (da)
NO (1) NO962841L (da)
NZ (1) NZ279062A (da)
RO (1) RO116525B1 (da)
RU (1) RU2161487C2 (da)
WO (1) WO1995018622A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
ES2211184T3 (es) 1998-08-06 2004-07-01 Wolfgang Stremmel Fosfatidilcolina como medicamento con efecto protector de mucosas.
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
AU2001267823A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
CA2420576C (en) 2000-08-29 2005-06-14 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
TWI314457B (da) * 2001-03-19 2009-09-11 Shionogi & Co
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US7825132B2 (en) 2002-08-23 2010-11-02 Novartis Vaccines And Diagnostics, Inc. Inhibition of FGFR3 and treatment of multiple myeloma
EP1565187A4 (en) 2002-11-13 2010-02-17 Novartis Vaccines & Diagnostic CANCER TREATMENT METHODS AND RELATED METHODS
ATE554752T1 (de) 2004-02-06 2012-05-15 Pharmatel R & D Pty Ltd As Trustee For The Pharmatel R & D Trust Verwendung von aminosalicylaten beim reizdarmsyndrom mit durchfall als vorherrschendem symptom
CA2556872C (en) 2004-02-20 2015-05-12 Chiron Corporation Modulation of inflammatory and metastatic processes
FR2867981B1 (fr) 2004-03-24 2008-10-31 Genevrier Sa Lab Utilisation des chondroitine mono-et disulfates en therapeutique
CN1988897B (zh) * 2004-05-28 2011-06-29 萨利克斯药物有限公司 巴柳氮在制备治疗因放射所引起的肠炎的药物的应用
US20080306029A1 (en) * 2004-05-28 2008-12-11 Salix Pharmaceuticals, Inc. Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
MX2007014206A (es) 2005-05-13 2008-02-07 Novartis Ag Metodos para tratar cancer resistente a los farmacos.
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
NZ565974A (en) * 2005-08-24 2012-07-27 Salix Pharmaceuticals Ltd Balsalazide formulations and manufacture and use thereof
RU2354384C1 (ru) * 2007-12-28 2009-05-10 Михаил Владимирович Кутушов Применение органических красителей в качестве средства для лечения онкологических заболеваний
WO2010030781A2 (en) * 2008-09-10 2010-03-18 Numed International, Inc. Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancer
EP2298321A1 (en) 2009-08-26 2011-03-23 Nordic Pharma Novel pharmaceutical compositions for treating IBD
BR122014009845A2 (pt) 2010-04-26 2015-12-29 Salix Pharmaceuticals Ltd usos de balsalazida para preparação de composição farmacêutica para tratamento de distúrbio gastrointestinal e induzir remissão clínica de colite ulcerativa em indivíduos do sexo masculino, bem como para diminuir o escore de mmdai e cicatrização da mucosa em indivíduos do sexo masculino com colite ulcerativa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080796B (en) * 1980-07-21 1983-10-12 Biorex Laboratories Ltd 2-hydroxy-5-phenylazobenzoic acid derivatives
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
US5162202A (en) * 1989-12-12 1992-11-10 Shamsuddin Abulkalam M Rectal mucus test and kit for detecting cancerous and precancerous conditions
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents

Also Published As

Publication number Publication date
JP4601466B2 (ja) 2010-12-22
CN1140994A (zh) 1997-01-22
DE69534564T2 (de) 2006-07-27
FI962735A (fi) 1996-08-26
CZ286460B6 (en) 2000-04-12
FI962735A0 (fi) 1996-07-03
AU691869B2 (en) 1998-05-28
ES2248796T3 (es) 2006-03-16
CA2180571A1 (en) 1995-07-13
NO962841L (no) 1996-08-29
HU9601846D0 (en) 1996-09-30
CZ196796A3 (en) 1996-12-11
EP0738152A1 (en) 1996-10-23
WO1995018622A1 (en) 1995-07-13
US5498608A (en) 1996-03-12
JP2010235629A (ja) 2010-10-21
DE69534564D1 (de) 2005-12-08
AU1557595A (en) 1995-08-01
RO116525B1 (ro) 2001-03-30
RU2161487C2 (ru) 2001-01-10
EP0738152B1 (en) 2005-11-02
JPH09510958A (ja) 1997-11-04
EP0738152A4 (en) 2000-12-13
JP2005320326A (ja) 2005-11-17
NZ279062A (en) 1999-11-29
CA2180571C (en) 2001-03-20
JP2006096738A (ja) 2006-04-13
ATE308327T1 (de) 2005-11-15
HUT74512A (en) 1997-01-28
NO962841D0 (no) 1996-07-05

Similar Documents

Publication Publication Date Title
DK0738152T3 (da) Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer
DK1033981T3 (da) Formuleringer og fremgangsmåder til nedsættelse af antineoplastiske midlers toksicitet
ATE306261T1 (de) Antithrombosemittel
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
DE69830504D1 (de) Antithrombotische mitteln
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
DK1313467T3 (da) Hidtil ukendte farmaceutiske præparater til indgivelse af N-0923
HUP9803044A2 (hu) Ibuprofentartalmú készítmény
PT1447399E (pt) Derivado de 2-oxo-1-pirrolidina e as suas utilizacoes farmaceuticas
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
BR0210139A (pt) Composições farmacêuticas
DE69930648D1 (de) Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
DE69819539D1 (de) Antithrombotische mittel
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
ATE286395T1 (de) Antithrombotische mittel
DE69635775D1 (de) Medikament gegen pulmonale herzprobleme
EA200602199A1 (ru) Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
SE9902742D0 (sv) New pharmaceutical formultion
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
FR2861992B1 (fr) Composition pharmaceutique destinee a l&#39;administration orale d&#39;un derive de pyrazole-3-carboxamide.